Alkem Laboratories Limited

IncreasedQuarterly

ALKEMPharmaceuticalsMarket Cap₹66K Cr

Stake

1.45% → 1.78%

DSP Mutual Fund

Mutual Fund

The move

DSP Mutual Fund increased its stake in Alkem Laboratories from 1.45% to 1.78% by purchasing 398,949 shares for ₹223.61 crore at ₹5606.00 apiece.

About Alkem Laboratories Limited

Visit stock

A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.

About DSP Mutual Fund

Visit investor

Standalone AMC after DSP Group acquired full ownership from BlackRock in 2018. Manages over Rs 1.9 lakh crore. Known for equity funds with a clear process-first culture and minimal star manager dependency. CEO Kalpen Parekh is widely respected for transparent investor communication. DSP Small Cap Fund and DSP Midcap Fund are flagship offerings.

Get the next move the moment it happens.

Follow DSP Mutual Fund and Alkem Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Alkem Laboratories Limited shareholders DSP Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Alkem Laboratories Limited

HDFC Mutual FundIncreased

HDFC Mutual Fund bought 25,019 shares of Alkem Laboratories in the open market. This purchase raised its stake from 5.00% to 5.02%, crossing the 5% disclosure threshold.

24 Aug 2026

LICDecreased

LIC decreased its stake in Alkem Laboratories by selling 147,955 shares, reducing its holding from 1.56% to 1.43%. The value of the shares sold is ₹82.26 crore at ₹5563.00 apiece.